Tsoukas MA, Woo V, Tobe SW, Slee A, et al. Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS Program and CREDENCE. Diabetes Obes Metab 2023 Mar 21. doi: 10.1111/dom.15057.
PMID: 36942888